Publications

This fact sheet gives an overview of domestic legislation that may have affect entities handling security sensitive biological agents (SSBAs).

Learn about security sensitive biological agents (SSBAs) that can be used both for good and for harm. This is known as ‘dual-use’. Exporting these SSBAs is monitored.

This fact sheets gives an overview of international conventions that may have implications for entities handling security sensitive biological agents (SSBAs).

These procedures explain how laboratories should collect and handle samples from patients with suspected viral haemorrhagic fevers.

This master plan sets out the vision for the delivery of aged care services across the Torres Strait and Northern Peninsula region. It identifies the need for integrated aged care delivery that meets the community’s needs and preferences.

This report provides advice about a national framework for continuous quality improvement in Aboriginal and Torres Strait Islander primary health care.

This fact sheet outlines which entities are exempt from the Security Sensitive Biological Agents (SSBA) Regulatory Scheme.

Use this guide to help you identify some of the key requirements of tobacco plain packaging for non-cigarette products such as cigars, roll-your-own tobacco and shisha/waterpipe tobacco.

An evaluation from 2012 to 2014 assessed the Cape York Wellbeing Centres. It looked at whether the centres reduced alcohol and substance abuse and harm in the community. This 2014 report presents the findings.

Use this guide to help you identify some of the key requirements of tobacco plain packaging.

This report presents long-term, national workforce projections for doctors to 2030. It is part of our series on Australia’s Future Health Workforce.

These reports present long-term, national workforce projections for nurses to 2030. They are part of our series on Australia’s Future Health Workforce.

These reports provide the results of the oral health workforce planning projections. They are part of our series on Australia’s Future Health Workforce.

This guide is to help approved aged care providers deliver services in residential aged care.

The evaluation was extremely positive and strongly supported Australia’s reputation as a world leader in implementing school-based immunisation programs and preventing HPV-related cancers and disease.

This document shows how much we spent in 2013–14 on stoma appliances and products under the Stoma Appliance Scheme.

This document is a template of a mental health treatment plan. Doctors can use it when referring patients for treatment under the Better Access to Psychiatrists, Psychologists and General Practitioners through the MBS initiative.

This document explains how to collect, handle, package and transport viral haemorrhagic fever samples.

This fact sheet provides information about follow-up health services to Medicare Benefits Schedule (MBS) annual health assessments for Aboriginal and Torres Strait Islander people, when provided by a practice nurse or an Aboriginal or Torres Strait Islander health practitioner (MBS item 10987).

This form is for existing participants seeking to access this program at a new location, or transfer from one of the other OMPs programs.

This 2014 report describes the alcohol and other drug (AOD) treatment system and funding processes in Australia. It provides options for future funding that respond to the needs of individuals, families and communities.

This guideline helps entities, facilities and individuals to interpret the National Health Security Regulations when handling samples from a person or animal affected by a security sensitive biological agent (SSBA).

This guideline explains the difference between the loss, theft or accidental release of a security sensitive biological agent (SSBA). It does not set out legal definitions, but outlines what must happen if an SSBA is lost or stolen or accidentally released during its handling at a facility.

This guideline outlines the process entities or facilities should follow if an incident happens that must be reported to either law enforcement or the National Security Hotline.

This guideline informs entities and facilities about handling toxins on the List of SSBAs. It covers the reportable quantities for toxins on the list and when to register for a Tier 1 or a Tier 2 SSBA if handling Clostridium botulinum.